INVA
Innoviva Inc.
Company Overview
| Mkt Cap | $1.21B | Price | $18.20 |
| Volume | 668.02K | Change | +1.39% |
| P/E Ratio | 51.7 | Open | $17.85 |
| Revenue | $358.7M | Prev Close | $17.95 |
| Net Income | $23.4M | 52W Range | $16.52 - $22.00 |
| Div Yield | N/A | Target | $36.20 |
| Overall | 53 | Value | 70 |
| Quality | -- | Technical | 36 |
No chart data available
Stock Overview
Updated DailyInnoviva Inc. (INVA) is a leading Healthcare company in the Biotechnology industry, currently trading at $18.20 with a market capitalization of $1.21 billion. The stock is in the lower portion of its trading range, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows INVA with a volume of 668K shares. The stock opened down 0.56% from yesterday's close of $17.95. Current analyst estimates project earnings of $1.98 per share for this year, with next year targeting $2.17.
INVA demonstrates concerning technical signals based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including OMHE, OILS-CA, OGN, ONPH.
Key investment considerations for INVA include average overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 98.9%. The stock shows reasonable valuation levels based on valuation analysis.
Analysis generated on November 2, 2025 at 09:09 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | INVA | $18.20 | +1.4% | 668.02K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |